nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.036	0.037	CcSEcCtD
Methyldopa—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.036	0.037	CcSEcCtD
Methyldopa—Liver disorder—Esomeprazole—Barrett's esophagus	0.0299	0.0308	CcSEcCtD
Methyldopa—Liver disorder—Omeprazole—Barrett's esophagus	0.0299	0.0308	CcSEcCtD
Methyldopa—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.0204	0.021	CcSEcCtD
Methyldopa—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.0204	0.021	CcSEcCtD
Methyldopa—Gynaecomastia—Omeprazole—Barrett's esophagus	0.0183	0.0188	CcSEcCtD
Methyldopa—Lightheadedness—Omeprazole—Barrett's esophagus	0.0183	0.0188	CcSEcCtD
Methyldopa—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.0183	0.0188	CcSEcCtD
Methyldopa—Lightheadedness—Esomeprazole—Barrett's esophagus	0.0183	0.0188	CcSEcCtD
Methyldopa—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.0164	0.0169	CcSEcCtD
Methyldopa—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.0164	0.0169	CcSEcCtD
Methyldopa—Mesalazine—PPARG—Barrett's esophagus	0.0139	0.51	CrCbGaD
Methyldopa—Breast disorder—Omeprazole—Barrett's esophagus	0.0134	0.0138	CcSEcCtD
Methyldopa—Breast disorder—Esomeprazole—Barrett's esophagus	0.0134	0.0138	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.0133	0.0137	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.0133	0.0137	CcSEcCtD
Methyldopa—Abdominal distension—Omeprazole—Barrett's esophagus	0.0129	0.0133	CcSEcCtD
Methyldopa—Abdominal distension—Esomeprazole—Barrett's esophagus	0.0129	0.0133	CcSEcCtD
Methyldopa—Pancreatitis—Esomeprazole—Barrett's esophagus	0.0126	0.0129	CcSEcCtD
Methyldopa—Pancreatitis—Omeprazole—Barrett's esophagus	0.0126	0.0129	CcSEcCtD
Methyldopa—Angina pectoris—Omeprazole—Barrett's esophagus	0.0125	0.0128	CcSEcCtD
Methyldopa—Angina pectoris—Esomeprazole—Barrett's esophagus	0.0125	0.0128	CcSEcCtD
Methyldopa—Pancytopenia—Esomeprazole—Barrett's esophagus	0.0122	0.0125	CcSEcCtD
Methyldopa—Pancytopenia—Omeprazole—Barrett's esophagus	0.0122	0.0125	CcSEcCtD
Methyldopa—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.0118	0.0121	CcSEcCtD
Methyldopa—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.0118	0.0121	CcSEcCtD
Methyldopa—Weight increased—Esomeprazole—Barrett's esophagus	0.0117	0.012	CcSEcCtD
Methyldopa—Weight increased—Omeprazole—Barrett's esophagus	0.0117	0.012	CcSEcCtD
Methyldopa—Infestation NOS—Omeprazole—Barrett's esophagus	0.0114	0.0117	CcSEcCtD
Methyldopa—Infestation—Omeprazole—Barrett's esophagus	0.0114	0.0117	CcSEcCtD
Methyldopa—Infestation NOS—Esomeprazole—Barrett's esophagus	0.0114	0.0117	CcSEcCtD
Methyldopa—Infestation—Esomeprazole—Barrett's esophagus	0.0114	0.0117	CcSEcCtD
Methyldopa—Jaundice—Esomeprazole—Barrett's esophagus	0.0111	0.0114	CcSEcCtD
Methyldopa—Jaundice—Omeprazole—Barrett's esophagus	0.0111	0.0114	CcSEcCtD
Methyldopa—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.0108	0.0111	CcSEcCtD
Methyldopa—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.0108	0.0111	CcSEcCtD
Methyldopa—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.0107	0.011	CcSEcCtD
Methyldopa—Agranulocytosis—Omeprazole—Barrett's esophagus	0.0107	0.011	CcSEcCtD
Methyldopa—Bradycardia—Esomeprazole—Barrett's esophagus	0.0104	0.0107	CcSEcCtD
Methyldopa—Bradycardia—Omeprazole—Barrett's esophagus	0.0104	0.0107	CcSEcCtD
Methyldopa—Hepatitis—Esomeprazole—Barrett's esophagus	0.0102	0.0105	CcSEcCtD
Methyldopa—Hepatitis—Omeprazole—Barrett's esophagus	0.0102	0.0105	CcSEcCtD
Methyldopa—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0101	0.0104	CcSEcCtD
Methyldopa—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0101	0.0104	CcSEcCtD
Methyldopa—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00924	0.0095	CcSEcCtD
Methyldopa—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00924	0.0095	CcSEcCtD
Methyldopa—Mental disorder—Esomeprazole—Barrett's esophagus	0.00898	0.00923	CcSEcCtD
Methyldopa—Mental disorder—Omeprazole—Barrett's esophagus	0.00898	0.00923	CcSEcCtD
Methyldopa—Flatulence—Esomeprazole—Barrett's esophagus	0.00879	0.00904	CcSEcCtD
Methyldopa—Flatulence—Omeprazole—Barrett's esophagus	0.00879	0.00904	CcSEcCtD
Methyldopa—Leukopenia—Omeprazole—Barrett's esophagus	0.00799	0.00821	CcSEcCtD
Methyldopa—Leukopenia—Esomeprazole—Barrett's esophagus	0.00799	0.00821	CcSEcCtD
Methyldopa—Myalgia—Esomeprazole—Barrett's esophagus	0.0076	0.00781	CcSEcCtD
Methyldopa—Arthralgia—Omeprazole—Barrett's esophagus	0.0076	0.00781	CcSEcCtD
Methyldopa—Myalgia—Omeprazole—Barrett's esophagus	0.0076	0.00781	CcSEcCtD
Methyldopa—Arthralgia—Esomeprazole—Barrett's esophagus	0.0076	0.00781	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00754	0.00775	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00754	0.00775	CcSEcCtD
Methyldopa—Aminosalicylic Acid—PTGS2—Barrett's esophagus	0.00748	0.274	CrCbGaD
Methyldopa—Infection—Omeprazole—Barrett's esophagus	0.00723	0.00744	CcSEcCtD
Methyldopa—Infection—Esomeprazole—Barrett's esophagus	0.00723	0.00744	CcSEcCtD
Methyldopa—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00714	0.00734	CcSEcCtD
Methyldopa—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00714	0.00734	CcSEcCtD
Methyldopa—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00713	0.00733	CcSEcCtD
Methyldopa—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00713	0.00733	CcSEcCtD
Methyldopa—Skin disorder—Omeprazole—Barrett's esophagus	0.00707	0.00727	CcSEcCtD
Methyldopa—Skin disorder—Esomeprazole—Barrett's esophagus	0.00707	0.00727	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00663	0.00682	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00663	0.00682	CcSEcCtD
Methyldopa—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00654	0.00672	CcSEcCtD
Methyldopa—Paraesthesia—Omeprazole—Barrett's esophagus	0.00654	0.00672	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00629	0.00646	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00629	0.00646	CcSEcCtD
Methyldopa—Constipation—Omeprazole—Barrett's esophagus	0.00623	0.0064	CcSEcCtD
Methyldopa—Constipation—Esomeprazole—Barrett's esophagus	0.00623	0.0064	CcSEcCtD
Methyldopa—Mesalazine—PTGS2—Barrett's esophagus	0.00587	0.215	CrCbGaD
Methyldopa—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00576	0.00592	CcSEcCtD
Methyldopa—Body temperature increased—Omeprazole—Barrett's esophagus	0.00576	0.00592	CcSEcCtD
Methyldopa—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00536	0.00551	CcSEcCtD
Methyldopa—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00536	0.00551	CcSEcCtD
Methyldopa—Asthenia—Esomeprazole—Barrett's esophagus	0.00522	0.00537	CcSEcCtD
Methyldopa—Asthenia—Omeprazole—Barrett's esophagus	0.00522	0.00537	CcSEcCtD
Methyldopa—Diarrhoea—Omeprazole—Barrett's esophagus	0.00498	0.00512	CcSEcCtD
Methyldopa—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00498	0.00512	CcSEcCtD
Methyldopa—Dizziness—Omeprazole—Barrett's esophagus	0.00481	0.00495	CcSEcCtD
Methyldopa—Dizziness—Esomeprazole—Barrett's esophagus	0.00481	0.00495	CcSEcCtD
Methyldopa—Vomiting—Esomeprazole—Barrett's esophagus	0.00463	0.00476	CcSEcCtD
Methyldopa—Vomiting—Omeprazole—Barrett's esophagus	0.00463	0.00476	CcSEcCtD
Methyldopa—Rash—Omeprazole—Barrett's esophagus	0.00459	0.00472	CcSEcCtD
Methyldopa—Rash—Esomeprazole—Barrett's esophagus	0.00459	0.00472	CcSEcCtD
Methyldopa—Dermatitis—Esomeprazole—Barrett's esophagus	0.00459	0.00472	CcSEcCtD
Methyldopa—Dermatitis—Omeprazole—Barrett's esophagus	0.00459	0.00472	CcSEcCtD
Methyldopa—Headache—Omeprazole—Barrett's esophagus	0.00456	0.00469	CcSEcCtD
Methyldopa—Headache—Esomeprazole—Barrett's esophagus	0.00456	0.00469	CcSEcCtD
Methyldopa—Nausea—Omeprazole—Barrett's esophagus	0.00433	0.00445	CcSEcCtD
Methyldopa—Nausea—Esomeprazole—Barrett's esophagus	0.00433	0.00445	CcSEcCtD
